Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.

Rudraraju R, Mordant F, Subbarao K.

J Infect Dis. 2019 Apr 8;219(Supplement_1):S81-S87. doi: 10.1093/infdis/jiy703. No abstract available.

PMID:
30715386
2.

Passive immunization with influenza haemagglutinin specific monoclonal antibodies.

Rudraraju R, Subbarao K.

Hum Vaccin Immunother. 2018;14(11):2728-2736. doi: 10.1080/21645515.2018.1489947. Epub 2018 Jul 16.

3.

Antigen presenting cell-targeted proinsulin expression converts insulin-specific CD8+ T-cell priming to tolerance in autoimmune-prone NOD mice.

Reeves PLS, Rudraraju R, Wong FS, Hamilton-Williams EE, Steptoe RJ.

Eur J Immunol. 2017 Sep;47(9):1550-1561. doi: 10.1002/eji.201747089. Epub 2017 Jul 18.

4.

APC-targeted proinsulin expression inactivates insulin-specific memory CD8+ T cells in NOD mice.

Reeves PL, Rudraraju R, Liu X, Wong FS, Hamilton-Williams EE, Steptoe RJ.

Immunol Cell Biol. 2017 Oct;95(9):765-774. doi: 10.1038/icb.2017.48. Epub 2017 Jun 14.

PMID:
28611473
5.

Allergen-encoding bone marrow transfer inactivates allergic T cell responses, alleviating airway inflammation.

Al-Kouba J, Wilkinson AN, Starkey MR, Rudraraju R, Werder RB, Liu X, Law SC, Horvat JC, Brooks JF, Hill GR, Davies JM, Phipps S, Hansbro PM, Steptoe RJ.

JCI Insight. 2017 Jun 2;2(11). pii: 85742. doi: 10.1172/jci.insight.85742. eCollection 2017 Jun 2.

6.

Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance.

Bhatt KH, Rudraraju R, Brooks JF, Jung JW, Galea R, Wells JW, Steptoe RJ.

Stem Cell Res Ther. 2017 Mar 9;8(1):57. doi: 10.1186/s13287-017-0508-3.

7.

Respiratory syncytial virus human experimental infection model: provenance, production, and sequence of low-passaged memphis-37 challenge virus.

Kim YI, DeVincenzo JP, Jones BG, Rudraraju R, Harrison L, Meyers R, Cehelsky J, Alvarez R, Hurwitz JL.

PLoS One. 2014 Nov 21;9(11):e113100. doi: 10.1371/journal.pone.0113100. eCollection 2014.

8.

Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin A deficient mice.

Surman SL, Jones BG, Sealy RE, Rudraraju R, Hurwitz JL.

Vaccine. 2014 May 7;32(22):2521-4. doi: 10.1016/j.vaccine.2014.03.025. Epub 2014 Mar 21.

9.

Intranasal administration of retinyl palmitate with a respiratory virus vaccine corrects impaired mucosal IgA response in the vitamin A-deficient host.

Surman SL, Jones BG, Rudraraju R, Sealy RE, Hurwitz JL.

Clin Vaccine Immunol. 2014 Apr;21(4):598-601. doi: 10.1128/CVI.00757-13. Epub 2014 Feb 19.

10.

Respiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A.

Rudraraju R, Jones BG, Surman SL, Sealy RE, Thomas PG, Hurwitz JL.

PLoS One. 2014 Jan 22;9(1):e86554. doi: 10.1371/journal.pone.0086554. eCollection 2014.

11.

Non-random lymphocyte distribution among virus-infected cells of the respiratory tract.

Rudraraju R, Sealy RE, Surman SL, Thomas PG, Dayton BH, Hurwitz JL.

Viral Immunol. 2013 Dec;26(6):378-84. doi: 10.1089/vim.2013.0033.

12.

Respiratory syncytial virus: current progress in vaccine development.

Rudraraju R, Jones BG, Sealy R, Surman SL, Hurwitz JL.

Viruses. 2013 Feb 5;5(2):577-94. doi: 10.3390/v5020577. Review.

13.

Vitamin A deficiency disrupts vaccine-induced antibody-forming cells and the balance of IgA/IgG isotypes in the upper and lower respiratory tract.

Surman SL, Rudraraju R, Sealy R, Jones B, Hurwitz JL.

Viral Immunol. 2012 Aug;25(4):341-4. doi: 10.1089/vim.2012.0023. Epub 2012 Jul 19.

14.

Reduced frequencies and heightened CD103 expression among virus-induced CD8(+) T cells in the respiratory tract airways of vitamin A-deficient mice.

Rudraraju R, Surman SL, Jones BG, Sealy R, Woodland DL, Hurwitz JL.

Clin Vaccine Immunol. 2012 May;19(5):757-65. doi: 10.1128/CVI.05576-11. Epub 2012 Mar 7.

15.

Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.

Jones BG, Sealy RE, Rudraraju R, Traina-Dorge VL, Finneyfrock B, Cook A, Takimoto T, Portner A, Hurwitz JL.

Vaccine. 2012 Jan 20;30(5):959-68. doi: 10.1016/j.vaccine.2011.11.046. Epub 2011 Nov 23. Erratum in: Vaccine. 2012 Nov 6;30(48):6955. Dosage error in article text.

16.

Clonally related CD8+ T cells responsible for rapid population of both diffuse nasal-associated lymphoid tissue and lung after respiratory virus infection.

Surman SL, Rudraraju R, Woodland DL, Dash P, Thomas PG, Hurwitz JL.

J Immunol. 2011 Jul 15;187(2):835-41. doi: 10.4049/jimmunol.1100125. Epub 2011 Jun 20.

17.

Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut.

Rudraraju R, Surman S, Jones B, Sealy R, Woodland DL, Hurwitz JL.

Virology. 2011 Feb 20;410(2):429-436. doi: 10.1016/j.virol.2010.12.017. Epub 2011 Jan 11.

18.
19.

A pilot study on the seroprevalence of parvovirus B19 infection.

Abraham M, Rudraraju R, Kannangai R, George K, Cherian T, Daniel D, Ramalingam S, Sridharan G.

Indian J Med Res. 2002 Apr;115:139-43.

PMID:
12239835

Supplemental Content

Loading ...
Support Center